Clinical trial
Aripiprazole for the Treatment of Schizophrenia With Co-Morbid Social Anxiety
NCT00177008 · University of Medicine and Dentistry of New Jersey, Other · Completed
Key facts
| NCT number | NCT00177008 |
|---|---|
| Title | Aripiprazole for the Treatment of Schizophrenia With Co-Morbid Social Anxiety |
| Official title | Aripiprazole for the Treatment of Schizophrenia With Co-Morbid Social Anxiety |
| Lead sponsor | University of Medicine and Dentistry of New Jersey, Other |
| Collaborators | Bristol-Myers Squibb Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Schizophrenia, Schizoaffective Disorder, Social Anxiety Disorder |
| Intervention type | Drug |
| Interventions | Aripiprazole |
| Enrollment | 18 |
| Start date | Mar 1, 2004 |
| Completion | Jan 1, 2007 |
| First posted | Sep 15, 2005 |
| Last update posted | Jan 29, 2007 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: